Primary Site >> Colorectal Cancer

Gene >> SUCO

  • 1992
  • 1995
  • 1996
  • 1997
  • 1998
  • 1999
  • 2000
  • 2002
  • 2004
  • 2005
  • 2007
  • 2008
  • 2009
  • 2010
  • 2011
  • 2012
  • 2013
  • 2014
  • 2015
  • 2016
  • 2017
  • 2018
Ref: Radiotherapy for locoregional relapses of rectal carcinoma after initial radical surgery: definite but limited influence on relapse-free survival and survival.
PMID: 1526862
Ref: Human/mouse chimeric antibodies show low reactivity with human anti-murine antibodies (HAMA).
PMID: 1739617
Ref: Biological properties of chimeric domain-deleted anticarcinoma immunoglobulins.
PMID: 7493377
Ref: Anticancer Drug Development: The Way Forward.
PMID: 10387985
Ref: Genetic engineering of a recombinant fusion possessing anti-tumor F(ab')2 and tumor necrosis factor.
PMID: 9165756
Ref: [Emergency surgery in inflammatory bowel disease. Experience in 26 cases].
PMID: 10210930
Ref: Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification.
PMID: 10344734
Ref: Regulation of beta -catenin transformation by the p300 transcriptional coactivator.
PMID: 11050151
Ref: [The malignant side of chronic inflammatory bowel disease].
PMID: 12532661
Ref: Diagnosis and management of dysplasia in patients with inflammatory bowel diseases.
PMID: 15168373
Ref: Synthesis, crystal structure and cytotoxicity of new oxaliplatin analogues indicating that improvement of anticancer activity is still possible.
PMID: 15276304
Ref: SJG-136 (NSC 694501), a novel rationally designed DNA minor groove interstrand cross-linking agent with potent and broad spectrum antitumor activity: part 1: cellular pharmacology, in vitro and initial in vivo antitumor activity.
PMID: 15374986
Ref: Radioiodinated anti-TAG-72 humanized CH2 domain-deleted antibody
PMID: 20641585
Ref: Redox-active antineoplastic ruthenium complexes with indazole: correlation of in vitro potency and reduction potential.
PMID: 15828821
Ref: Reversion of structure-activity relationships of antitumor platinum complexes by acetoxime but not hydroxylamine ligands.
PMID: 17050805
Ref: Selective treatment of rectal cancer with single-stage coloanal or ultralow colorectal anastomosis does not adversely affect morbidity and mortality.
PMID: 17361396
Ref: The first ruthenium-based paullones: syntheses, X-ray diffraction structures, and spectroscopic and antiproliferative properties in vitro.
PMID: 17402728
Ref: Novel di- and tetracarboxylatoplatinum(IV) complexes. Synthesis, characterization, cytotoxic activity, and DNA platination.
PMID: 18031001
Ref: Synthesis, structure, spectroscopic properties, and antiproliferative activity in vitro of novel osmium(III) complexes with azole heterocycles.
PMID: 18597450
Ref: Synthesis, structures and in vitro cytotoxicity of some platinum(II) complexes containing thiocarbamate esters.
PMID: 18707761
Ref: Novel bis(carboxylato)dichlorido(ethane-1,2-diamine)platinum(IV) complexes with exceptionally high cytotoxicity.
PMID: 18755512
Ref: Novel endothall-containing platinum(IV) complexes: synthesis, characterization, and cytotoxic activity.
PMID: 18972539
Ref: Tumour cell survival signalling by the ERK1/2 pathway.
PMID: 18846109
Ref: Opt-out plus, the patients' choice: preferences of cancer patients concerning information and consent regimen for future research with biological samples archived in the context of treatment.
PMID: 19017681
Ref: Synthesis, X-ray diffraction structure, spectroscopic properties and antiproliferative activity of a novel ruthenium complex with constitutional similarity to cisplatin.
PMID: 19421637
Ref: Highly cytotoxic copper(II) complexes with modified paullone ligands.
PMID: 19968251
Ref: Preferences for colorectal cancer screening strategies: a discrete choice experiment.
PMID: 20197766
Ref: Structure-activity relationships of highly cytotoxic copper(II) complexes with modified indolo[3,2-c]quinoline ligands.
PMID: 20979395
Ref: Consent for biobanking: assessing the understanding and views of cancer patients.
PMID: 21173381
Ref: Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.
PMID: 21523759
Ref: En route to osmium analogues of KP1019: synthesis, structure, spectroscopic properties and antiproliferative activity of trans-[Os(IV)Cl4(Hazole)2].
PMID: 21739939
Ref: Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin.
PMID: 21940073
Ref: The genetics of familial adenomatous polyposis (FAP) and MutYH-associated polyposis (MAP).
PMID: 22103048
Ref: Solid-phase synthesis of oxaliplatin-TAT peptide bioconjugates.
PMID: 22281694
Ref: Reflex immunohistochemistry and microsatellite instability testing of colorectal tumors for Lynch syndrome among US cancer programs and follow-up of abnormal results.
PMID: 22355048
Ref: Osmium(IV) complexes with 1H- and 2H-indazoles: tautomer identity versus spectroscopic properties and antiproliferative activity.
PMID: 22687494
Ref: A bioluminescent transposon reporter-trap identifies tumor-specific microenvironment-induced promoters in Salmonella for conditional bacterial-based tumor therapy.
PMID: 22728436
Ref: L- and D-proline thiosemicarbazone conjugates: coordination behavior in solution and the effect of copper(II) coordination on their antiproliferative activity.
PMID: 22889304
Ref: Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.
PMID: 22976974
Ref: Ruthenium- and osmium-arene complexes of 8-substituted indolo[3,2-c]quinolines: Synthesis, X-ray diffraction structures, spectroscopic properties, and antiproliferative activity.
PMID: 23471093
Ref: Randomized controlled trial of a video decision support tool for cardiopulmonary resuscitation decision making in advanced cancer.
PMID: 23233708
Ref: Are cancer registries a viable tool for cancer survivor outreach? A feasibility study.
PMID: 23247719
Ref: Short communication: lack of occult HIV infection among non-AIDS-defining cancer patients in three academic oncology clinics in the United States.
PMID: 23351216
Ref: Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.
PMID: 23431223
Ref: [Faecal occult blood test for colorectal cancer screening: high quality for a good price].
PMID: 23594877
Ref: Evolving role of neoadjuvant therapy in rectal cancer.
PMID: 23828092
Ref: The first 1000 patients on an internet-based colorectal neoplasia database across private and public medicine in Australia: development of a binational model for the Colorectal Surgical Society of Australia and New Zealand.
PMID: 24401877
Ref: Preferences for cancer investigation: a vignette-based study of primary-care attendees.
PMID: 24433682
Ref: Guanidine platinum(II) complexes: synthesis, in vitro antitumor activity, and DNA interactions.
PMID: 24444821
Ref: Current and Future Status for Evaluation of Dysplasia and Carcinoma in IBD.
PMID: 24477467
Ref: Ruthenium-nitrosyl complexes with glycine, L-alanine, L-valine, L-proline, D-proline, L-serine, L-threonine, and L-tyrosine: synthesis, X-ray diffraction structures, spectroscopic and electrochemical properties, and antiproliferative activity.
PMID: 24555845
Ref: Predictors of adherence to screening guidelines for chronic diseases of lifestyle, cancers, and HIV in a health-insured population in South Africa.
PMID: 24647130
Ref: A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.
PMID: 25032896
Ref: [Colorectal Carcinoma with Suspected Lynch Syndrome: A Multidisciplinary Algorithm].
PMID: 25372301
Ref: Optimizing long-circulating liposomes for delivery of simvastatin to C26 colon carcinoma cells.
PMID: 25487170
Ref: Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.
PMID: 25879501
Ref: Tetracarboxylatoplatinum(IV) complexes featuring monodentate leaving groups - A rational approach toward exploiting the platinum(IV) prodrug strategy.
PMID: 26365319
Ref: Consent to Donate Surgical Biospecimens for Research: Perceptions of People With Colorectal Cancer.
PMID: 26050142
Ref: Combined Epiregulin and Amphiregulin Expression Levels as a Predictive Biomarker for Panitumumab Therapy Benefit or Lack of Benefit in Patients With RAS Wild-Type Advanced Colorectal Cancer.
PMID: 26867820
Ref: Chalcone derivatives cause accumulation of colon cancer cells in the G2/M phase and induce apoptosis.
PMID: 26916824
Ref: Universal tumor screening for Lynch syndrome: health-care providers' perspectives.
PMID: 27711070
Ref: {Ru(CO)x}-Core complexes with benzimidazole ligands: synthesis, X-ray structure and evaluation of anticancer activity in vivo.
PMID: 28207024
Ref: Impact of the equatorial coordination sphere on the rate of reduction, lipophilicity and cytotoxic activity of platinum(IV) complexes.
PMID: 28666155
Ref: A case of local recurrence of T1 rectal cancer 10 years after transanal excision.
PMID: 29581623
Ref: ERBB2 and KRAS Alterations Mediate Response to EGFR Inhibitors in Early Stage Gallbladder Cancer.
PMID: 30304546